CN Patent

CN113134086B — 一种降血脂的药物组合物

Assigned to Shenzhen Changqing Medical Science Research Institute · Expires 2024-05-24 · 2y expired

What this patent protects

本发明提供一种用于降低血脂的药物组合物，由Bempedoic acid、贝特类降脂药、叶酸及适量辅料组成。本发明提供的药物组合物针对高血脂患者提供一种有效的药物，且三药联用，具有协同增效的作用。另外，本药物组合物还可以使患者服药方便，提高依从性，降低医疗费用。

USPTO Abstract

本发明提供一种用于降低血脂的药物组合物，由Bempedoic acid、贝特类降脂药、叶酸及适量辅料组成。本发明提供的药物组合物针对高血脂患者提供一种有效的药物，且三药联用，具有协同增效的作用。另外，本药物组合物还可以使患者服药方便，提高依从性，降低医疗费用。

Drugs covered by this patent

Patent Metadata

Patent number
CN113134086B
Jurisdiction
CN
Classification
—
Expires
2024-05-24
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Changqing Medical Science Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.